Anticancer Potential of Artemisia Annua

10k
Total downloads
30k
Total views and downloads

Articles

EDITORIAL

Published on 24 Feb 2022

Editorial: Anticancer Potential of Artemisia annua

Jill M. Kolesar
Peter H. Seeberger

doi 10.3389/fonc.2022.853406

4,595 views
2 citations

ORIGINAL RESEARCH

Published on 07 Feb 2022

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Olesya Vakhrusheva
Holger H. H. Erb
Vitus Bräunig
Sascha D. Markowitsch
Patricia Schupp
Patrick C. Baer
Kimberly Sue Slade
Anita Thomas
Igor Tsaur
6 more
Eva Juengel

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

doi 10.3389/fonc.2022.789284

4,486 views
17 citations

ORIGINAL RESEARCH

Published on 11 Jan 2022

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology

Amanda B. Kagan
Blake S. Moses
Bryan T. Mott
Ganesha Rai
Nicole M. Anders
Michelle A. Rudek
Curt I. Civin

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology

doi 10.3389/fonc.2021.790037

1,411 views
6 citations

ORIGINAL RESEARCH

Published on 03 Jan 2022

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

Xinyu Zhou
Abel Soto-Gamez
Fleur Nijdam
Rita Setroikromo
Wim J. Quax

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

doi 10.3389/fonc.2021.789336

2,632 views
10 citations

ORIGINAL RESEARCH

Published on 24 Nov 2021

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1

Deeptashree Nandi
Pradeep Singh Cheema
Aakriti Singal
Hina Bharti
Alo Nag

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1

doi 10.3389/fonc.2021.751271

2,531 views
9 citations

ORIGINAL RESEARCH

Published on 02 Nov 2021

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

You-Cai Yi
Rui Liang
Xiao-Yu Chen
Hui-Ning Fan
Ming Chen
Jing Zhang
Jin-Shui Zhu

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling

doi 10.3389/fonc.2021.768879

4,018 views
20 citations

ORIGINAL RESEARCH

Published on 22 Oct 2021

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer

Qingrong Li
Qiang Ma
Lei Xu
Chuanli Gao
Lihua Yao
Jilin Wen
Miyuan Yang
Jibing Cheng
Xi Zhou
2 more
Xiaolan Guo

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer

doi 10.3389/fphar.2021.769787

2,268 views
4 citations

ORIGINAL RESEARCH

Published on 12 Aug 2021

Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

Bochao Geng
Yuanzhang Zhu
Yingying Yuan
Jingyi Bai
Zhizhi Dou
Aihua Sui
Wenjuan Luo

Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

doi 10.3389/fonc.2021.714646

2,823 views
14 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Pharmacology of Anti-Cancer Drugs
Cancer Molecular Targets and Therapeutics

Participating Journals

Frontiers in Pharmacology
- Cancer Molecular Targets and TherapeuticsOffline
- Pharmacology of Anti-Cancer Drugs
- 4.4 impact factor
- 7.8 citescore

Impact

30kTopic views
19kArticle views
10kArticle downloads